Cargando…
Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia
Autores principales: | Yeo, Min-Kyung, Park, Hee Sun, Park, Yeon Hee, Lee, Choong-Sik, Yoo, Geon, Park, Dong Il, Lee, Jeong Eun, Moon, Jae Young, Jung, Sung Soo, Kim, Ju Ock, Kang, Dahyun, Cho, Hyun Jin, Kang, Min-Woong, Kim, Jin-Whan, Kim, Song-Soo, Chung, Chaeuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850685/ https://www.ncbi.nlm.nih.gov/pubmed/29483403 http://dx.doi.org/10.4103/0366-6999.226059 |
Ejemplares similares
-
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018) -
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019) -
The effector of Hippo signaling, Taz, is required for formation of the micropyle and fertilization in zebrafish
por: Yi, Xiaogui, et al.
Publicado: (2019) -
The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla, et al.
Publicado: (2016) -
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
por: Kang, Da Hyun, et al.
Publicado: (2020)